PREMIUM

  • GRACE PAUL

    Madrid

Monday, March 1, 2021 - 02:28

  • Share on Facebook

  • Share on Twitter

  • Send by email

  • Live.

    Coronavirus, live

  • Graphic.

    This is how vaccination progresses, CCAA by CCAA

The question is common among those who receive the long-awaited appointment to be vaccinated, "which one are you going to get?".

In Spain, three possibilities are already being considered: that of Pfizer, that of Moderna and that which seems to be the least popular (at least in neighboring countries), that of AstraZeneca. Vaccines licensed so far present

spectacular efficacy data in their clinical trials

.

Somewhat more variable in disease prevention

Become Premium and


enjoy 3 months for € 1

Take advantage of this limited time offer and access all web content

I love you

Are you already Premium?

Log in

Cancel whenever you want

Check the terms and conditions of the service

According to the criteria of The Trust Project

Know more